LABORATORIO FARMAC.ERFO Financial Flexibility Index
LABORATORIO FARMAC.ERFO financial flexibility index. LABORATORIO FARMAC.ERFO (RK7) has a Financial Flexibility Index of 1.21x as of December 2023. Free cash flow of €2.74 Million (operating CF €1.30 Million minus capex €1.45 Million) represents 1% of total liabilities (€2.26 Million). See LABORATORIO FARMAC.ERFO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of LABORATORIO FARMAC.ERFO (2021–2023)
Financial flexibility index of LABORATORIO FARMAC.ERFO from 2021 to 2023. Historical Financial Flexibility Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. Check RK7 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
LABORATORIO FARMAC.ERFO Financial Flexibility Index by Year (2021–2023)
LABORATORIO FARMAC.ERFO financial flexibility index by year from 2021 to 2023. Year-by-year free cash flow to debt coverage for LABORATORIO FARMAC.ERFO. For the full cash flow conversion analysis, see RK7 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.21x | €2.74 Million | €1.30 Million | €2.26 Million | ▲ +557.6% |
| 2022 | 0.18x | €1.94 Million | €761.80K | €10.53 Million | ▼ -83.9% |
| 2021 | 1.14x | €2.52 Million | €2.27 Million | €2.21 Million | — |